Australia Report: Monash Healthcare

  American Journal of Infection Control 24 month trial

To download a copy of this report, click or tap here.


In 2016, a report was published in the American Journal of Infection Control testing the antibacterial efficacy of Endurocide® Antimicrobial Plus Curtains 24 months after installation.

Organised by one of Australia’s largest public health services, every six months over a period of twenty-four months Zone of Inhibition and Contact Inhibition testing was carried out against a range of multi-resistant microorganisms, including:

  • Gram positive bacteria (MRSA, VRE E.faecium)
  • Gram negative bacteria (Pseudomonas aeruginosa, ESBL E.coli)
  • Fungi (Candida albicans)
  • Spores (Clostridium difficile)
ajic diamond+

To download a copy of this report, click or tap here.

*The cost savings were based on comparing the use of Endurocide® Antimicrobial Plus Curtains with traditional cotton cubicle curtains, not only in regards to the initial purchasing costs but to the saving of labour and laundering over two years.

For further information on our trials, please contact us.

DISCLAIMER: While Endurocide®  Antimicrobial Plus Curtains have been independently tested to remain antimicrobially and sporicidally effective for up to two years in-situ, the actual length of curtain use achieved will depend on a variety of factors, including, but not limited to; individual hospital practices, the natural longevity of polypropylene and the risk of the curtain being soiled from items such as blood, urine and general spills etc.  Curtains should always be replaced when visibly soiled. Any timescales provided/referenced are always offered as a guideline only and under no circumstances whatsoever constitute a guarantee.